Login to Your Account

Success, Better Technology Drive Pharma's Antibody Lust

By Jennifer Boggs

Monday, September 15, 2008
ATLANTA - There's no question that "antibodies have come a long way in the last 20 to 25 years," said Fritz Rudert, general manager of German consulting firm FHR Consult and moderator of a panel on antibodies at the first annual BioPharm America conference. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription